BB Biotech AG / Director's Dealings announcement according to §15a WpHG (the German Securities Trading Act) . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement.
| Details of the person subject to the disclosure requirement | |||||
| Name: | Koller, Daniel | ||||
| Professional role: | Person with executive functions: Â Member of a managing body | ||||
| Â | Â | ||||
| Designation of the financial instrument | |||||
| ISIN: | CH0038389992 | ||||
| Designation: | Registered share | ||||
| Â | Â | ||||
| Details of the transaction | |||||
| Type of transaction: | Buy | ||||
| Date: | 25.03.2013 | ||||
| Place (stock exchange): | SIX Swiss Exchange | ||||
| Price: | 104.80 | ||||
| Currency: | CHF | ||||
| Quantity: | 200 | ||||
| Business volume: | 20960 | ||||
| Â | Â | ||||
| Details of the company with the publishing obligation: | |||||
| Issuer: | |||||
| BB Biotech AG | |||||
| Vordergasse 3 | |||||
| CH-8200 Â Schaffhausen | |||||
| Switzerland | |||||
| |||||
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: BB Biotech AG via Thomson Reuters ONE
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: BB Biotech AG via Thomson Reuters ONE
HUG#1688344
--- End of Message ---
BB Biotech AG
Vordergasse 3 Schaffhausen Switzerland
WKN: 888509;ISIN: CH0038389992;Index:TecDAX,MIDCAP,Prime All Share,TECH All Share,HDAX;
Listed: Regulierter Markt in Frankfurter Wertpapierbörse;
© 2013 GlobeNewswire (Europe)
